This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
€30,800,000
Total raised
-
Valuation
-
Employees
2023
Founded
Latest round
Series A - November 13, 2026
Series A - €30,800,000
November 13, 2026
Norrsken VC - Verified by the Sesamers desk Singular - Verified by the Sesamers desk HCVC - Verified by the Sesamers desk InfraVia Growth - Verified by the Sesamers desk Patient Autonome Fund - Verified by the Sesamers desk Plug and Play - Verified by the Sesamers desk Serena - Verified by the Sesamers desk Speedinvest - Verified by the Sesamers desk Teampact Ventures - Verified by the Sesamers desk Verve Ventures - Verified by the Sesamers desk
InfraVia Growth, Serena, Patient Autonome Fund (Bpifrance), teampact.ventures, Plug and Play, Verve Ventures, Speedinvest, HCVC, Thomas Wolf, Stan Polu, Jacques Boitreaud, Mostafa El Sayed
✓ verified by our desk
Open roles
Orakl Oncology is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile